Wall Street Zen Downgrades LifeStance Health Group (NASDAQ:LFST) to Buy

LifeStance Health Group (NASDAQ:LFST) was downgraded by equities researchers at Wall Street Zen from a “strong-buy” rating to a “buy” rating in a research note issued on Saturday, Wall Street Zen reports.

A number of other research firms have also weighed in on LFST. JPMorgan Chase & Co. upped their price target on shares of LifeStance Health Group from $9.00 to $13.00 and gave the stock a “neutral” rating in a research report on Friday, August 14th. Weiss Ratings upgraded LifeStance Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, August 11th. KeyCorp raised their price target on LifeStance Health Group from $11.00 to $13.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Barclays increased their target price on LifeStance Health Group from $9.00 to $13.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. Finally, Zacks Research downgraded LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 13th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $12.38.

LifeStance Health Group Stock Performance

Shares of LFST opened at $12.73 on Friday. The business has a 50-day simple moving average of $11.49 and a two-hundred day simple moving average of $8.81. The company has a quick ratio of 1.38, a current ratio of 1.38 and a debt-to-equity ratio of 0.18. LifeStance Health Group has a 52 week low of $4.77 and a 52 week high of $13.15. The stock has a market cap of $4.94 billion, a price-to-earnings ratio of 97.93 and a beta of 1.22.

LifeStance Health Group (NASDAQ:LFST) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.06 earnings per share for the quarter, beating analysts’ consensus estimates of $0.03 by $0.03. The firm had revenue of $435.35 million for the quarter, compared to analysts’ expectations of $414.58 million. LifeStance Health Group had a return on equity of 3.39% and a net margin of 3.19%.The business’s quarterly revenue was up 26.1% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.01) EPS. On average, analysts expect that LifeStance Health Group will post 0.16 EPS for the current year.

Insider Activity at LifeStance Health Group

In related news, major shareholder Tpg Gp A, Llc sold 13,643,207 shares of the business’s stock in a transaction dated Monday, August 10th. The stock was sold at an average price of $10.62, for a total value of $144,890,858.34. Following the sale, the insider directly owned 98,101,407 shares in the company, valued at approximately $1,041,836,942.34. The trade was a 12.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CTO Vukasin Paunovich sold 42,067 shares of the stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $12.87, for a total value of $541,402.29. Following the transaction, the chief technology officer directly owned 205,379 shares of the company’s stock, valued at approximately $2,643,227.73. The trade was a 17.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 14,671,917 shares of company stock worth $155,493,415 in the last quarter. 3.50% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Allianz Asset Management GmbH bought a new stake in LifeStance Health Group in the second quarter worth $1,152,000. HighTower Advisors LLC bought a new stake in shares of LifeStance Health Group in the 2nd quarter worth about $794,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of LifeStance Health Group during the 2nd quarter valued at about $248,000. California State Teachers Retirement System lifted its holdings in shares of LifeStance Health Group by 1,433.6% in the 2nd quarter. California State Teachers Retirement System now owns 2,546,988 shares of the company’s stock valued at $27,278,000 after acquiring an additional 2,380,904 shares during the last quarter. Finally, Turner Financial Group Inc. bought a new position in shares of LifeStance Health Group in the 2nd quarter valued at about $251,000. 85.50% of the stock is currently owned by institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.